drugset / Trial / NCT03634917
Investigation of the Efficacy of Acamprosate and Calcium in Comparison to Placebo as Validation of a Behavioural Test for Alcohol Dependence
RandomizedParallel-groupTriple-blindBasic science
Summary
Validation of a Test System to develop new medications for alcoholism (TEMA) The 'TEMA', a progressive-work alcohol self-administration paradigm, can be validated by reproducing the effect of Acamprosate and prove the effect of Calcium to reduce motivation to work for alcohol after 14 - 19 days of treatment during a period of 15 - 20 days of alcohol abstinence in a randomized, double-blind, placebo-controlled three-arm parallel-group design.
Timeline
- Start
- 2020-08-05
- Primary completion
- 2023-08-30
- Completion
- 2024-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Acamprosate | Small molecule | 666 mg | Oral |
| Comparator | Calcium carbonate | Other / unclassified | 1500 mg | Oral |